Integrated and first trimester prenatal screening in California: Program implementation and patient choice for follow-up services

Prenatal Diagnosis

Volumn 32, Issue 11, 2012, Pages 1077-1083

  Currier, Robert ^a   Wu, Nerissa ^a   Van Meter, Karla ^a   Goldman, Sara ^a   Lorey, Fred ^a   Flessel, Monica ^a  

^a CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; DOWN SYNDROME; ETHNICITY; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; FOLLOW UP; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; PATIENT DECISION MAKING; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; UNITED STATES;

ADULT; CALIFORNIA; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 13; DELIVERY OF HEALTH CARE, INTEGRATED; DOWN SYNDROME; FEMALE; FOLLOW-UP STUDIES; HEALTH PLAN IMPLEMENTATION; HUMANS; MIDDLE AGED; PATIENT PREFERENCE; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS; TRISOMY; YOUNG ADULT;

EID: 84868112966     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.3961     Document Type: Article

References (11)

1. Kazerouni NN, Currier RJ, Flessel M, et al. Detection rate of quadruple-marker screening determined by clinical follow-up and registry data in the statewide California program, July 2007 to February 2009. Prenat Diagn 2011;31(9):901-6.
2. Palomaki GE, Steinort K, Knight GJ, et al. Comparing three screening strategies for combining first- and second-trimester Down syndrome markers. Obstet Gynecol 2006;107(2 Pt 1):367-75.
3. Cuckle HS, Wald NJ, Thompson SG. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol 1987;94(5):387-402.
4. Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Royston P, Chard T, et al. Maternal serum screening for Down's syndrome in early pregnancy. BMJ 1988;297(6653):883-7.
5. Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). Health Technol Assess 2003;7(11):1-77.
6. Palomaki GE, Neveux LM, Knight GJ, Haddow JE. Maternal serum-integrated screening for trisomy 18 using both first- and second-trimester markers. Prenat Diagn 2003;23(3):243-7.
7. Spencer K, Nicolaides KH. A first trimester trisomy 13/trisomy 18 risk algorithm combining fetal nuchal translucency thickness, maternal serum free beta-hCG and PAPP-A. Prenat Diagn 2002;22(10):877-9.
8. Tul N, Spencer K, Noble P, Chan C, Nicolaides K. Screening for trisomy 18 by fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A at 10-14weeks of gestation. Prenat Diagn 1999;19(11):1035-42.
9. Palomaki GE, Bradley LA, Knight GJ, Craig WY, Haddow JE. Assigning risk for Smith-Lemli-Opitz syndrome as part of 2nd trimester screening for Down's syndrome. J Med Screen 2002;9(1):43-4.
10. GDSP. Prenatal Diagnosis Center Standards and Definitions. 2012. URL http://www.cdph.ca.gov/programs/GDSP/Documents/Standards%202012.pdf [accessed on 19 March 2012].
11. AIUM Practice Guideline for the Performance of Obstetric Ultrasound Examinations. URL http://www.aium.org/publications/guidelinesEnhanced/obstetric.aspx [accessed on 6 July 2012].